Heparin activates antithrombin anticoagulant function by generating new interaction sites (exosites) for blood clotting proteinases.

[1]  M. Backovic,et al.  Insight into residues critical for antithrombin function from analysis of an expanded database of sequences that includes frog, turtle, and ostrich antithrombins. , 2002, Journal of proteome research.

[2]  S. Krishnaswamy,et al.  The Contribution of Factor Xa to Exosite-dependent Substrate Recognition by Prothrombinase* , 2002, The Journal of Biological Chemistry.

[3]  J. Whisstock,et al.  The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins , 2001, The Journal of Biological Chemistry.

[4]  S. Olson,et al.  The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation. , 2001, Biochemistry.

[5]  J. Beechem,et al.  Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes. , 2001, Biochemistry.

[6]  S. Olson,et al.  Heparin Enhances the Specificity of Antithrombin for Thrombin and Factor Xa Independent of the Reactive Center Loop Sequence , 2001, The Journal of Biological Chemistry.

[7]  R. Pike,et al.  Evolution of Serpin Specificity: Cooperative Interactions in the Reactive-Site Loop Sequence of Antithrombin Specifically Restrict the Inhibition of Activated Protein C , 2000, Journal of Molecular Evolution.

[8]  R. Read,et al.  Structure of a serpin–protease complex shows inhibition by deformation , 2000, Nature.

[9]  H. Saito,et al.  Complete antithrombin deficiency in mice results in embryonic lethality. , 2000, The Journal of clinical investigation.

[10]  W Ruf,et al.  Exosite Interactions Determine the Affinity of Factor X for the Extrinsic Xase Complex* , 2000, The Journal of Biological Chemistry.

[11]  R. Carrell,et al.  The Conformational Activation of Antithrombin , 2000, The Journal of Biological Chemistry.

[12]  S. Muhammad,et al.  Partitioning of Serpin-Proteinase Reactions between Stable Inhibition and Substrate Cleavage Is Regulated by the Rate of Serpin Reactive Center Loop Insertion into β-Sheet A* , 2000, The Journal of Biological Chemistry.

[13]  P. Gettins,et al.  Serine 380 (P14) --> glutamate mutation activates antithrombin as an inhibitor of factor Xa. , 2000, The Journal of biological chemistry.

[14]  S. Olson,et al.  Importance of the P2 Glycine of Antithrombin in Target Proteinase Specificity, Heparin Activation, and the Efficiency of Proteinase Trapping as Revealed by a P2 Gly → Pro Mutation* , 1999, The Journal of Biological Chemistry.

[15]  P. Gettins,et al.  Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Rezaie.  Calcium Enhances Heparin Catalysis of the Antithrombin-Factor Xa Reaction by a Template Mechanism , 1998, The Journal of Biological Chemistry.

[17]  J. Abrahams,et al.  The anticoagulant activation of antithrombin by heparin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Carrell,et al.  Heparin-dependent Modification of the Reactive Center Arginine of Antithrombin and Consequent Increase in Heparin Binding Affinity* , 1997, The Journal of Biological Chemistry.

[19]  van Boven Hh,et al.  Antithrombin and its inherited deficiency states. , 1997 .

[20]  B. L. Le Bonniec,et al.  Intrinsic Specificity of the Reactive Site Loop of α1-Antitrypsin, α1-Antichymotrypsin, Antithrombin III, and Protease Nexin I* , 1997, The Journal of Biological Chemistry.

[21]  J. Whisstock,et al.  The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site. , 1997, Journal of molecular biology.

[22]  S. Olson,et al.  Antithrombin. A bloody important serpin. , 1997, Advances in experimental medicine and biology.

[23]  D. Ginsburg,et al.  Chemistry and Biology of Serpins , 1997, Advances in Experimental Medicine and Biology.

[24]  Robert Huber,et al.  X-ray Structure of Active Site-inhibited Clotting Factor Xa , 1996, The Journal of Biological Chemistry.

[25]  J. Huntington,et al.  Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding. , 1996, Biochemistry.

[26]  C. Tapparelli,et al.  Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis. , 1996, Biochemistry.

[27]  R. Carrell,et al.  Development of a Novel Recombinant Serpin with Potential Antithrombotic Properties (*) , 1995, The Journal of Biological Chemistry.

[28]  S. Olson,et al.  Kinetic Characterization of the Proteinase Binding Defect in a Reactive Site Variant of the Serpin, Antithrombin , 1995, The Journal of Biological Chemistry.

[29]  S. Stone,et al.  Interaction of activated protein C with serpins. , 1993, The Biochemical journal.

[30]  I. Turko,et al.  Transmission of conformational change from the heparin binding site to the reactive center of antithrombin. , 1993, Biochemistry.

[31]  P. Grootenhuis,et al.  Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site. , 1993, The Journal of biological chemistry.

[32]  S. Olson,et al.  Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. , 1992, The Journal of biological chemistry.

[33]  C. Esmon,et al.  Thrombin Glu-39 restricts the P'3 specificity to nonacidic residues. , 1991, The Journal of biological chemistry.

[34]  P. George,et al.  P1 variant antithrombins Glasgow (393 Arg to His) and Pescara (393 Arg to Pro) have increased heparin affinity and are resistant to catalytic cleavage by elastase Implications for the heparin activation mechanism , 1991, FEBS letters.

[35]  J. Hofsteenge,et al.  Effect of heparin on the glia-derived-nexin-thrombin interaction. , 1989, The Biochemical journal.

[36]  Å. Danielsson,et al.  Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. , 1986, The Journal of biological chemistry.

[37]  D. Atha,et al.  Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. , 1986, The Journal of biological chemistry.

[38]  M. Petitou,et al.  Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. , 1983, Biochemical and biophysical research communications.

[39]  J H Lewis,et al.  Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. , 1983, The New England journal of medicine.

[40]  U Lindahl,et al.  Further characterization of the antithrombin-binding sequence in heparin. , 1982, Carbohydrate research.